CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Option exercise Director acquired 112,179 shares (option exercise)
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 4 Option exercise Director acquired 80,128 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Executive Vice President & CFO acquired 87,719 shares (option exercise)
- 4 Shares withheld for taxes Executive Vice President gave up 18,064 shares (to pay taxes)
Page 15 of 35 · 695 filings